Averto Medical, Inc., formerly known as Savage Medical, Inc., is a clinical-stage medical device company dedicated to transforming gastrointestinal care. Its first product, the ColoSeal™ Intraluminal Colonic Diversion System enables procedures such as colorectal cancer resection without the need to create an invasive temporary diverting stoma. Averto Medical is backed by a syndicate of leading healthcare institutional investors.
